ISRCTN12617867
Active, not recruiting
未知
This study aims to assess the post-market safety and performance of a range of contact lens types
CooperVision Inc Ltd0 sites700 target enrollmentAugust 16, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Myopia, astigmatism, hyperopia, presbyopia
- Sponsor
- CooperVision Inc Ltd
- Enrollment
- 700
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 8 to 75 years (inclusive).
- •2\. They understand their rights as a research subject and are willing to sign a Statement of Informed Consent
- •3\. Current wearer (for at least 6 months) of CE\-marked CooperVision test or control lenses. Equivalent private\-label contact lenses can be included in either group
Exclusion Criteria
- •Participation in a contact lens or contact lens care product clinical trial within the previous 30 days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Post-market clinical follow-up for stenfilcon A sphere and toric lensesMyopia, astigmatism, hyperopiaEye DiseasesISRCTN61640561CooperVision105
Completed
Phase 4
Post market study to evaluate safety and effectiveness of the InnFocus MicroShunt® (MIDI Arrow) in patients with primary open angle glaucomaPrimary open-angle glaucoma10018307NL-OMON42294Innfocus Inc.25
Recruiting
Not Applicable
Prospective, Post-market Evaluation of Safety and Efficacy of a Local Osteo-Enhancement Procedure (LOEP) in the Proximal Femur of Women in Europe With Osteoporosisproximal femur with high risk for fragility fractureosteoporosisproximal femur bone mineral densityNL-OMON51693AgNovos Healthcare30
Not yet recruiting
Not Applicable
Post-market study of Pipit-NC Balloon Dilatation CatheterHealth Condition 1: I209- Angina pectoris, unspecifiedCTRI/2023/08/056616Sahajanand Medical Technologies Ltd. (SMT)
Completed
Not Applicable
Post-market surveillance study to prove the safety and performance of Vanguard PS RPKnee joint deseasesJPRN-UMIN000023965Zimmer Biomet G.K.100